Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02224755 · ClinicalTrials.gov registry record · NA
MOMENTUM 3 IDE Clinical Study Protocol
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,028
- Enrollment target
NCT02224755: Completed NA study, sponsored by Abbott Medical Devices.
NCT02224755 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,028 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02224755, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,028 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the safety and effectiveness of the HM3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure.
Primary Outcome
Survival at 6 months free of disabling stroke (Modified Rankin Score \> 3) or reoperation to replace or remove a malfunctioning device
Interventions
- DEVICE HeartMate 3 LVAS
- DEVICE HeartMate II LVAS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,028 participants |
| Start Date | 2014-09-02 |
| Est. Completion | 2019-03-26 |
| Phase | NA |
What the finished NCT02224755 record still lists
NCT02224755 is an interventional study that assigns participants to a tested intervention. Its 1,028 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 2 interventions - of which HeartMate 3 LVAS is the first listed.
NCT02224755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02224755 about?
NCT02224755 is a clinical study titled "MOMENTUM 3 IDE Clinical Study Protocol". The objective of the study is to evaluate the safety and effectiveness of the HM3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure.
What is the current status of trial NCT02224755?
This trial is currently completed. It is a NA study. The enrollment target is 1,028 participants. The study started on 2014-09-02. Estimated completion is 2019-03-26.
What interventions are being tested in trial NCT02224755?
The interventions under investigation include: HeartMate 3 LVAS (DEVICE), HeartMate II LVAS (DEVICE).
Who is sponsoring clinical trial NCT02224755?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02224755's enrollment target sits among peer trials
1,028 104th of 2000 higher than 1,897 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI